Adoptive immunotherapy against ovarian cancer

The standard front-line therapy for epithelial ovarian cancer (EOC) is combination of debulking surgery and platinum-based chemotherapy. Nevertheless, the majority of patients experience disease recurrence. Although extensive efforts to find new therapeutic options, cancer cells invariably develop d...

Descripción completa

Detalles Bibliográficos
Autores principales: Mittica, Gloria, Capellero, Sonia, Genta, Sofia, Cagnazzo, Celeste, Aglietta, Massimo, Sangiolo, Dario, Valabrega, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869278/
https://www.ncbi.nlm.nih.gov/pubmed/27188274
http://dx.doi.org/10.1186/s13048-016-0236-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869278/
https://www.ncbi.nlm.nih.gov/pubmed/27188274
http://dx.doi.org/10.1186/s13048-016-0236-9

Ejemplares similares